RSLS logo

ReShape Lifesciences (RSLS) Cash From Investing

Annual CFI

-$10.00 K
+$82.00 K+89.13%

December 31, 2023


Summary


Performance

RSLS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLScash flowmetrics:

Quarterly CFI

$0.00
$0.000.00%

September 30, 2024


Summary


Performance

RSLS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLScash flowmetrics:

TTM CFI

$0.00
$0.000.00%

September 30, 2024


Summary


Performance

RSLS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLScash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

RSLS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+89.1%0.0%+100.0%
3 y3 years+99.6%+100.0%-100.0%
5 y5 years+99.9%+100.0%+100.0%

RSLS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.5%+89.1%-100.0%+100.0%-100.0%+100.0%
5 y5-year-100.5%+99.6%-100.0%+100.0%-100.0%+100.0%
alltimeall time-100.1%+99.9%-100.0%+100.0%-100.0%+100.0%

ReShape Lifesciences Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2024
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2024
-
$0.00(0.0%)
-$3000.00(-70.0%)
Dec 2023
-$10.00 K(-89.1%)
$0.00(0.0%)
-$10.00 K(-88.8%)
Sep 2023
-
$0.00(-100.0%)
-$89.00 K(-27.0%)
Jun 2023
-
-$3000.00(-57.1%)
-$122.00 K(+20.8%)
Mar 2023
-
-$7000.00(-91.1%)
-$101.00 K(+9.8%)
Dec 2022
-$92.00 K(-105.0%)
-$79.00 K(+139.4%)
-$92.00 K(-97.0%)
Sep 2022
-
-$33.00 K(-283.3%)
-$3.08 M(-1.8%)
Jun 2022
-
$18.00 K(+800.0%)
-$3.14 M(-258.7%)
Mar 2022
-
$2000.00(-100.1%)
$1.98 M(+6.5%)
Dec 2021
$1.85 M(-177.6%)
-$3.07 M(+3346.1%)
$1.85 M(-32.8%)
Sep 2021
-
-$89.00 K(-101.7%)
$2.76 M(+2.2%)
Jun 2021
-
$5.13 M(-4410.9%)
$2.70 M(-207.7%)
Mar 2021
-
-$119.00 K(-94.5%)
-$2.51 M(+5.0%)
Dec 2020
-$2.39 M(+18.7%)
-$2.16 M(+1359.5%)
-$2.39 M(+6.5%)
Sep 2020
-
-$148.00 K(+80.5%)
-$2.24 M(+7.1%)
Jun 2020
-
-$82.00 K(<-9900.0%)
-$2.10 M(+4.1%)
Mar 2020
-
$0.00(-100.0%)
-$2.01 M(0.0%)
Dec 2019
-$2.01 M(-80.5%)
-$2.01 M(<-9900.0%)
-$2.01 M(-80.5%)
Sep 2019
-
$0.00(0.0%)
-$10.32 M(0.0%)
Jun 2019
-
$0.00(-100.0%)
-$10.32 M(-0.1%)
Dec 2018
-$10.33 M(+62.2%)
-$10.32 M(<-9900.0%)
-$10.33 M(+133.8%)
Sep 2018
-
$0.00(-100.0%)
-$4.42 M(-2.3%)
Jun 2018
-
-$7000.00(<-9900.0%)
-$4.52 M(-29.0%)
Mar 2018
-
$0.00(-100.0%)
-$6.37 M(0.0%)
Dec 2017
-$6.37 M(>+9900.0%)
-$4.41 M(+4169.4%)
-$6.37 M(+224.9%)
Sep 2017
-
-$103.30 K(-94.4%)
-$1.96 M(+5.6%)
Jun 2017
-
-$1.85 M(<-9900.0%)
-$1.86 M(>+9900.0%)
Mar 2017
-
$0.00(-100.0%)
-$2500.00(-82.1%)
Dec 2016
-$14.00 K(-64.0%)
-$2500.00(<-9900.0%)
-$14.00 K(+6.1%)
Sep 2016
-
$0.00(0.0%)
-$13.20 K(-5.7%)
Jun 2016
-
$0.00(-100.0%)
-$14.00 K(-56.0%)
Mar 2016
-
-$11.50 K(+576.5%)
-$31.80 K(-18.5%)
DateAnnualQuarterlyTTM
Dec 2015
-$38.90 K(-56.1%)
-$1700.00(+112.5%)
-$39.00 K(-60.6%)
Sep 2015
-
-$800.00(-95.5%)
-$98.90 K(-14.7%)
Jun 2015
-
-$17.80 K(-4.8%)
-$115.90 K(+15.8%)
Mar 2015
-
-$18.70 K(-69.6%)
-$100.10 K(+12.9%)
Dec 2014
-$88.70 K(-58.9%)
-$61.60 K(+246.1%)
-$88.70 K(-153.0%)
Sep 2014
-
-$17.80 K(+790.0%)
$167.40 K(-181.9%)
Jun 2014
-
-$2000.00(-72.6%)
-$204.30 K(-7.0%)
Mar 2014
-
-$7300.00(-103.8%)
-$219.70 K(+1.7%)
Dec 2013
-$216.00 K(-123.4%)
$194.50 K(-149.9%)
-$216.00 K(-50.4%)
Sep 2013
-
-$389.50 K(+2138.5%)
-$435.10 K(-145.6%)
Jun 2013
-
-$17.40 K(+383.3%)
$954.40 K(-1.4%)
Mar 2013
-
-$3600.00(-85.4%)
$968.10 K(+4.8%)
Dec 2012
$923.60 K(-81.8%)
-$24.60 K(-102.5%)
$923.60 K(-68.5%)
Sep 2012
-
$1.00 M(<-9900.0%)
$2.94 M(-369.1%)
Jun 2012
-
-$3700.00(-92.3%)
-$1.09 M(-257.7%)
Mar 2012
-
-$48.10 K(-102.4%)
$691.70 K(-86.3%)
Dec 2011
$5.07 M(-177.6%)
$1.99 M(-165.7%)
$5.07 M(-247.0%)
Sep 2011
-
-$3.03 M(-270.1%)
-$3.45 M(+756.4%)
Jun 2011
-
$1.78 M(-58.9%)
-$402.50 K(-81.5%)
Mar 2011
-
$4.33 M(-166.3%)
-$2.18 M(-66.6%)
Dec 2010
-$6.53 M(-229.6%)
-$6.53 M(<-9900.0%)
-$6.53 M(>+9900.0%)
Sep 2010
-
$18.80 K(>+9900.0%)
-$22.60 K(-114.1%)
Jun 2010
-
$0.00(-100.0%)
$160.80 K(-78.4%)
Mar 2010
-
-$21.40 K(+7.0%)
$745.70 K(-85.2%)
Dec 2009
$5.04 M(+78.0%)
-$20.00 K(-109.9%)
$5.04 M(-42.9%)
Sep 2009
-
$202.20 K(-65.4%)
$8.82 M(+197.9%)
Jun 2009
-
$584.90 K(-86.3%)
$2.96 M(-43.9%)
Mar 2009
-
$4.27 M(+13.4%)
$5.28 M(+86.7%)
Dec 2008
$2.83 M(-65.7%)
$3.77 M(-166.5%)
$2.83 M(-402.7%)
Sep 2008
-
-$5.66 M(-294.7%)
-$935.20 K(-119.8%)
Jun 2008
-
$2.91 M(+59.8%)
$4.73 M(+159.8%)
Mar 2008
-
$1.82 M
$1.82 M
Dec 2007
$8.25 M(-146.7%)
-
-
Dec 2006
-$17.67 M(+3829.3%)
-
-
Dec 2005
-$449.80 K
-
-

FAQ

  • What is ReShape Lifesciences annual cash flow from investing activities?
  • What is the all time high annual CFI for ReShape Lifesciences?
  • What is ReShape Lifesciences annual CFI year-on-year change?
  • What is ReShape Lifesciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ReShape Lifesciences?
  • What is ReShape Lifesciences quarterly CFI year-on-year change?
  • What is ReShape Lifesciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ReShape Lifesciences?
  • What is ReShape Lifesciences TTM CFI year-on-year change?

What is ReShape Lifesciences annual cash flow from investing activities?

The current annual CFI of RSLS is -$10.00 K

What is the all time high annual CFI for ReShape Lifesciences?

ReShape Lifesciences all-time high annual cash flow from investing activities is $8.25 M

What is ReShape Lifesciences annual CFI year-on-year change?

Over the past year, RSLS annual cash flow from investing activities has changed by +$82.00 K (+89.13%)

What is ReShape Lifesciences quarterly cash flow from investing activities?

The current quarterly CFI of RSLS is $0.00

What is the all time high quarterly CFI for ReShape Lifesciences?

ReShape Lifesciences all-time high quarterly cash flow from investing activities is $5.13 M

What is ReShape Lifesciences quarterly CFI year-on-year change?

Over the past year, RSLS quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is ReShape Lifesciences TTM cash flow from investing activities?

The current TTM CFI of RSLS is $0.00

What is the all time high TTM CFI for ReShape Lifesciences?

ReShape Lifesciences all-time high TTM cash flow from investing activities is $8.82 M

What is ReShape Lifesciences TTM CFI year-on-year change?

Over the past year, RSLS TTM cash flow from investing activities has changed by +$89.00 K (+100.00%)